Publications by authors named "J M Capdevila"

Claim this Profile
S
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.
J Capdevila, S Tafuto, M Krogh, A Teulé, R Garcia-Carbonero

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).
Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo, Marta Benavent Viñuales, Rocio Garcia-Carbonero

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belzutifan for Advanced Pheochromocytoma or Paraganglioma.
Camilo Jimenez, Mikkel Andreassen, Alice Durand, Sophie Moog, Andrew Hendifar, Jaume Capdevila

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors.
R Dienstmann, A Vivancos, P Nuciforo, S Aguilar, F Ruiz-Pace, J Capdevila

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in -Mutant Medullary Thyroid Cancer.
Rossella Elisei, Lori J Wirth, Jaume Capdevila, Ana Oliveira Hoff, Makoto Tahara

Thyroid· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis